| Sitemap | Subscribe | Contact Us | ||
|
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest Other Medications Articles
FDA Approves Symlin Pen, But Forbids Symlin Use Without Bolus Insulin
14 November 2007
The Food and Drug Administration (FDA) just approved pre-filled pens for administering Symlin, which was previously available only in vials. The SymlinPen 60 delivers 15, 30, 45, or 60 micrograms per dose.
The SymlinPen 120 delivers 60 or 120 micrograms per dose. Both may be stored at room temperature, up to 86 degrees, after first use.
The FDA also issued a "Not Approvable" letter forbidding the use of Symlin in patients with type 2 who are using basal insulin but are not using meal-time, or bolus, insulin. Symlin is approved for use only in type 1s or type 2s who are using meal-time boluses and need more help with their blood sugar control.
Source: Amylin Press Release, September 2007
Recent Related Hot Topics...
18 comments - 1 May 2008
11 comments - 21 Apr 2008
8 comments - 28 Apr 2008
2 comments - 15 May 2008
1 comment - 21 Apr 2008
Comments...
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register..
Register your Diabetes Health Username here.
I prefer NOT to inject Gila Monster spit, thank you very much!
Symlin is not from Gila Monster. Actually Byetta is not the Gila Monster spit but a synthesised protein called exemtide or something like that. Byetta often reverses the symptoms of Diabetes in Type 2 patients who are not in good control on Diabetic Meds alone. So maybe you ought to rethink your premise.
Symlin is not made from Gila Monster spit as far as I know. It has just been announced today that in recent controlled tests that Symlin and Leptin have shown a 12.05% loss in weight over an 18 week period. This is remarkable and the first time a diabetic drug has posted this kind of results with non diabetics. It will be a block buster for Amylin eventually. With symlin now in a pen it will be used by many more persons. It is a health thing and now is the time for all of us.
I am happy! I stopped using symlin only because going back to carrying syringes and a vial felt like going back 20 years. I started pumping in 1987-88.
I tried Symlin many months ago, but I quit using it for the same reason I would always skip my insulin until I started pumping. I really hate giving shots and carring all that stuff with me. I can not wait to use the pen and see if my sugar and WEIGHT gets better again.
Typical FDA overprotectiveness. They are "worried" that Symlin would be taken to help a Type 2 lose weight (that is, they are protecting the diet food industry). The fact that Symlin would be taken without a bolus would actually be beneficial since it would reduce the most serious of the drug's side effects--hypoglycemia. FDA Idiots!
Symlin is a synthetic version of the pancreatic beta cell hormone called amylin which is completely absent in all patients with type 1 diabetes. It is in no way a weight loss drug. Although some patients report a very small weight loss, some doctors have speculated that the primary reason for this is because insulin requirements drop and calorie consumption is reduced. But the average weight loss in clinical trials was pretty marginal, in both patients with type 1 as well as those with type 2 diabetes, although type 2s lost more weight on average because they had a higher BMI on average to begin with.
Have Your Say...